脑监测市场 - 全球产业规模、份额、趋势、机会及预测（按设备、最终用户、应用、地区和竞争格局划分），2021-2031年

全球脑监测市场预计将从 2025 年的 37.8 亿美元成长到 2031 年的 55.7 亿美元，复合年增长率为 6.69%。

该市场涵盖用于评估神经系统参数（包括颅内压和脑电活动）的医疗设备和系统，以辅助诊断和治疗脑部疾病。该领域的成长主要受全球人口老化和需要紧急干预的神经系统疾病病例增加的推动。世界卫生组织 (WHO) 2024 年的报告显示，届时全球将有超过 30 亿人患有神经系统疾病，使其成为全球致残和致病的主要原因之一。这进一步增加了在慢性病和急性病护理环境中对可靠的诊断和监测解决方案的需求。

儘管这些成长指标令人鼓舞，但由于先进监测系统高成本且报销体系复杂，市场扩张仍面临许多障碍。此外，全球范围内熟练的神经科和专业医务人员短缺，也限制了这些技术的广泛应用。这种专业知识的匮乏严重阻碍了复杂生理数据的解读，在医疗基础设施不足以维护先进医疗设备的欠发达地区，这项挑战尤其严峻。

市场驱动因素

市场成长的主要驱动因素是神经退化性疾病发生率的上升和老龄化人口的不断扩大。随着世界人口老化，阿兹海默症、帕金森氏症和失智症疾病的盛行率不断上升，促使人们需要频繁且准确地进行神经系统评估。这一人口趋势迫使医疗保健机构实施先进的监测系统，以便早期发现疾病并进行持续管理，从而控制长期照护成本。根据阿兹海默症协会于2024年3月发布的《2024年阿兹海默症现况与统计》报告，约有690万65岁以上的美国人患有老年痴呆症失智症。患者数量的快速成长使得使用脑电图（EEG）和其他无创技术来监测疾病进展和治疗效果变得特别必要。

此外，人工智慧和技术创新与神经诊断工具的融合正在加速脑监测解决方案的普及。机器学习和讯号处理技术的进步使设备能够更精确地分析复杂的生理数据，从而吸引了该领域的大量投资。例如，Alto Neurosciences于2024年2月完成首次股票公开发行（IPO），筹集了约1.286亿美元，用于开发其基于脑电图（EEG）生物标誌物的精准精神病学平台。这标誌着该产业正向数据驱动的个人化医疗转型。此外，对神经学基础设施的大量投资也在推动这一趋势。Medtronic报告称，其神经科学产品组合在2024年创造了94亿美元的收入，显示全球资本配置对先进神经监测和干预能力的重要性。

市场挑战

全球脑监测市场成长面临的主要障碍之一是专业医护人员和熟练神经科的短缺。先进的脑监测系统会产生复杂的生理数据，需要专家分析才能提供临床价值。因此，当医疗机构缺乏操作这些设备和解读结果的训练有素的人员时，就很难证明购买如此昂贵设备的合理性。这种短缺有效地限制了市场渗透，尤其是在发展中地区，这些地区现有医疗技术与操作所需人力之间的差距最为显着。

随着神经系统疾病的增加，人才短缺直接削弱了市场需求。世界神经病学联合会报告称，到2024年，低收入国家每10万人口的神经科数量将比高所得国家少82倍。这种专业人才的巨大差距限制了医疗系统制定全面监测方案的能力。因此，儘管需要重症监护的疾病日益增多，但由于全球范围内缺乏使用这些诊断工具所需的专业人才，市场潜力仍未充分发挥。

市场趋势

携带式和穿戴式脑电监测设备的普及正在重塑市场格局，将诊断工作从神经科专科转移到加护病房和急诊室等第一线医疗机构。与传统笨重复杂的脑电图仪相比，这些紧凑型系统使临床医生能够在床边快速对疑似癫痫持续状态或非惊厥性癫痫发作的患者进行分诊。这种便利性的提升提高了急诊护理的工作流程效率，并显着缩短了诊断时间，从而促使医疗机构迅速采用这些设备。近期财务数据也反映了对这些灵活解决方案的需求。例如，Ceribell 在 2024 年第三季财报中报告称，由于其人工智慧驱动的可携式脑电图系统在各医院网路中的广泛应用，其总收入增长了 48%，达到 1720 万美元。

同时，远端患者监护和远距神经病学解决方案的蓬勃发展，正将神经诊断能力拓展到医院之外，支持对睡眠障碍和癫痫等慢性疾病进行居家管理。这项转变得益于医疗设备(SaMD) 模式和云端平台的进步，这些平台能够实现持续资料收集和远距医师诊断，有效填补了专科医生短缺造成的空白。随着分散式医疗保健的扩展，製造商正日益关注这些基于服务的收入来源。例如，Compumedics 公司在 2024 年 9 月宣布，软体即服务(SaaS) 远距监护部门贡献了 420 万美元的收入，显着加速了成长，并实现了该财年 4,970 万美元的创纪录收入。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球脑监测市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 透过设备（脑电图（EEG）、肌电图（EMG）、脑磁图（MEG）、颅内压（ICP）、MRI、fMRI、CT）
  • 依最终使用者（医院、神经科中心、诊所和门诊手术中心）划分
  • 依应用领域（创伤性脑损伤 (TBI)、中风、失智症、头痛障碍、睡眠障碍、巴金森氏症、癫痫、亨丁顿舞蹈症、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美脑监测市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲脑监测市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区脑监测市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲脑监测市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲脑监测市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球脑监测市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Dragerwerk AG & Co. KGaA
• Masimo Corporation
• Cadwell Industries, Inc.
• NuroWave Systems, Inc.
• Neurosoft SA
• CGX（A Cognionics Company）
• Natus Medical, Inc.
• Nihon Kohden Corporation
• Koninklijke Philips NV
• GE HealthCare Technologies Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Brain Monitoring Market is projected to expand from USD 3.78 Billion in 2025 to USD 5.57 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.69%. This market encompasses medical devices and systems engineered to evaluate neurological parameters, including intracranial pressure and electrical activity, to aid in diagnosing and managing brain disorders. The sector's growth is largely fueled by an aging global population and the increasing prevalence of neurological issues requiring critical intervention. As reported by the World Health Organization in 2024, over 3 billion individuals globally were living with a neurological condition, positioning these disorders as the primary cause of disability and illness worldwide, thereby intensifying the need for robust diagnostic and monitoring solutions in both chronic and acute care environments.

Despite these favorable growth indicators, market expansion faces significant hurdles due to the high costs of advanced monitoring systems and complex reimbursement frameworks. Additionally, the widespread adoption of these technologies is constrained by a global scarcity of skilled neurologists and specialized healthcare staff. This lack of expertise creates a critical bottleneck in the interpretation of intricate physiological data, a challenge that is particularly acute in developing regions where healthcare infrastructure is often inadequate to sustain sophisticated medical devices.

Market Driver

The primary catalysts for market growth are the rising incidence of neurodegenerative disorders and the expansion of the geriatric demographic. As the world's population ages, the prevalence of conditions like Alzheimer's disease, Parkinson's disease, and dementia rises, creating a critical need for frequent and accurate neurological assessments. This demographic trend compels healthcare providers to implement advanced monitoring systems for early detection and ongoing management to control long-term care expenses. According to the Alzheimer's Association's "2024 Alzheimer's Disease Facts and Figures" report from March 2024, approximately 6.9 million Americans aged 65 and older suffer from Alzheimer's dementia, a surge in patient volume that necessitates increased usage of electroencephalography (EEG) and other non-invasive methods to monitor disease progression and treatment success.

Furthermore, the integration of artificial intelligence and technological innovations in neurodiagnostic tools is accelerating the adoption of brain monitoring solutions. Advances in machine learning and signal processing allow devices to analyze complex physiological data with higher precision, drawing substantial investment into the field. For example, Alto Neuroscience announced the closing of its initial public offering in February 2024, securing roughly $128.6 million to develop a precision psychiatry platform using EEG biomarkers, highlighting the industry's pivot toward data-centric, personalized care. Additionally, broader investment in neurological infrastructure supports this trend; Medtronic reported that its Neuroscience portfolio generated $9.4 billion in revenue in 2024, demonstrating significant global capital allocation toward advanced neurological monitoring and intervention capabilities.

Market Challenge

A major obstacle hindering the growth of the Global Brain Monitoring Market is the scarcity of specialized healthcare personnel and skilled neurologists. Advanced brain monitoring systems produce intricate physiological data that demands expert analysis to provide clinical value. Consequently, when healthcare facilities lack trained staff capable of operating these devices or interpreting their results, justifying the purchase of such expensive equipment becomes challenging. This shortage effectively limits market penetration, especially in developing regions where the disparity between available medical technology and the workforce necessary to operate it is most severe.

This workforce limitation directly undermines the demand generated by the growing burden of neurological diseases. According to the World Federation of Neurology, in 2024, low-income nations had up to 82 times fewer neurologists per 100,000 inhabitants compared to high-income countries. This drastic inequality in specialized human resources limits the capacity of healthcare systems to establish comprehensive monitoring programs. As a result, even though the prevalence of conditions requiring critical care is increasing, the market remains unable to achieve its full potential because the essential expertise required to utilize these diagnostic tools is missing in large sectors of the global market.

Market Trends

The market is being reshaped by the proliferation of portable and wearable brain monitoring devices, which are shifting diagnostics from specialized neurology departments to point-of-care settings such as intensive care units and emergency rooms. In contrast to traditional, bulky EEG carts that necessitate complicated setups, these compact systems empower clinicians to quickly triage patients suspected of having status epilepticus or non-convulsive seizures directly at the bedside. This increased accessibility enhances workflow efficiency and significantly shortens the time to diagnosis in acute care environments, fueling rapid adoption by healthcare facilities. The demand for these agile solutions is reflected in recent financial data; for instance, Ceribell reported a 48% rise in total revenue to $17.2 million in its third-quarter 2024 financial results, driven by the wider use of its AI-enabled, portable EEG system across hospital networks.

Simultaneously, the growth of remote patient monitoring and tele-neurology solutions is expanding neuro-diagnostic capabilities beyond hospital confines, aiding in the home management of chronic conditions like sleep disorders and epilepsy. This transition is supported by the advancement of Software-as-a-Medical-Device (SaMD) models and cloud-based platforms that facilitate continuous data collection and remote review by physicians, effectively addressing the gaps created by specialist shortages. Manufacturers are increasingly targeting these service-based revenue streams to capitalize on decentralized care. Notably, Compumedics Limited announced in September 2024 that it achieved record revenues of $49.7 million for the fiscal year, with growth significantly bolstered by its software-as-a-service (SaaS) remote monitoring division, which contributed $4.2 million in revenue.

Key Market Players

• Dragerwerk AG & Co. KGaA
• Masimo Corporation
• Cadwell Industries, Inc.
• NuroWave Systems, Inc.
• Neurosoft SA
• CGX (A Cognionics Company)
• Natus Medical, Inc.
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.

Report Scope

In this report, the Global Brain Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brain Monitoring Market, By Device

• EEG
• EMG
• MEG
• ICP
• MRI
• fMRI
• CT

Brain Monitoring Market, By End-User

• Hospitals
• Neurology Centers
• Clinics & ASC

Brain Monitoring Market, By Application

• Traumatic brain injury (TBI)
• Stroke
• Dementia
• Headache disorders
• Sleep disorders
• Parkinson disease
• Epilepsy
• Huntington disease
• Other diseases

Brain Monitoring Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Brain Monitoring Market.

Available Customizations:

Global Brain Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brain Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device (EEG, EMG, MEG, ICP, MRI, fMRI, CT)
  • 5.2.2. By End-User (Hospitals, Neurology Centers, Clinics & ASC)
  • 5.2.3. By Application (Traumatic brain injury (TBI), Stroke, Dementia, Headache disorders, Sleep disorders, Parkinson disease, Epilepsy, Huntington disease, Other diseases)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Brain Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device
  • 6.2.2. By End-User
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Brain Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device
      • 6.3.1.2.2. By End-User
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Brain Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device
      • 6.3.2.2.2. By End-User
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Brain Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device
      • 6.3.3.2.2. By End-User
      • 6.3.3.2.3. By Application

7. Europe Brain Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device
  • 7.2.2. By End-User
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Brain Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device
      • 7.3.1.2.2. By End-User
      • 7.3.1.2.3. By Application
  • 7.3.2. France Brain Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device
      • 7.3.2.2.2. By End-User
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Brain Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device
      • 7.3.3.2.2. By End-User
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Brain Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device
      • 7.3.4.2.2. By End-User
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Brain Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device
      • 7.3.5.2.2. By End-User
      • 7.3.5.2.3. By Application

8. Asia Pacific Brain Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device
  • 8.2.2. By End-User
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Brain Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device
      • 8.3.1.2.2. By End-User
      • 8.3.1.2.3. By Application
  • 8.3.2. India Brain Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device
      • 8.3.2.2.2. By End-User
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Brain Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device
      • 8.3.3.2.2. By End-User
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Brain Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device
      • 8.3.4.2.2. By End-User
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Brain Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device
      • 8.3.5.2.2. By End-User
      • 8.3.5.2.3. By Application

9. Middle East & Africa Brain Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device
  • 9.2.2. By End-User
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Brain Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device
      • 9.3.1.2.2. By End-User
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Brain Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device
      • 9.3.2.2.2. By End-User
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Brain Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device
      • 9.3.3.2.2. By End-User
      • 9.3.3.2.3. By Application

10. South America Brain Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device
  • 10.2.2. By End-User
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Brain Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device
      • 10.3.1.2.2. By End-User
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Brain Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device
      • 10.3.2.2.2. By End-User
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Brain Monitoring Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device
      • 10.3.3.2.2. By End-User
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Brain Monitoring Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dragerwerk AG & Co. KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Masimo Corporation
• 15.3. Cadwell Industries, Inc.
• 15.4. NuroWave Systems, Inc.
• 15.5. Neurosoft SA
• 15.6. CGX (A Cognionics Company)
• 15.7. Natus Medical, Inc.
• 15.8. Nihon Kohden Corporation
• 15.9. Koninklijke Philips N.V.
• 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer